Skip to content

Brian J Roach

Northern California Institute for Research and Education, San Francisco, California; San Francisco Veterans Affairs Medical Center, San Francisco, California. Electronic address: brian.roach@ncire.org.

2 papers in the library · 7 citations · publishing 2020-2025

Papers

Gamma Oscillations and Excitation/Inhibition Imbalance: Parallel Effects of NMDA Receptor Antagonism and Psychosis.

Biological psychiatry. Cognitive neuroscience and neuroimaging January 18, 2025 Brian J Roach, Judith M Ford, Spero Nicholas et al. 7 citations

Abnormalities in the 40-Hz auditory steady-state response (ASSR), a measure of gamma-band brain activity, appear in schizophrenia and in animal models with reduced NMDA receptor function. This study compared 40-Hz ASSR deficits in schizophrenia patients to those induced by ketamine (an NMDA receptor antagonist) in healthy participants. Schizophrenia patients showed increased prestimulus broadband gamma power and reduced evoked power, total power, and phase-locking factor, replicating prior work, but no phase delay. Ketamine similarly increased prestimulus gamma power and reduced evoked power, total power, and phase-locking factor, while also advancing the ASSR phase. Direct comparison revealed significant differences only in phase, suggesting NMDA receptor hypofunction contributes to gamma oscillation abnormalities in schizophrenia.

Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression

medRxiv Preprint Server August 31, 2020 Steven Pennybaker, Brian J Roach, Susanna L Fryer et al. preprint

Older age is associated with slower and less durable antidepressant responses to intravenous ketamine in veterans with treatment-refractory depression. The study found that age-related declines in neuroplasticity may attenuate ketamine's mechanism of action, which involves glutamatergic signaling and synaptogenesis. Older patients took longer to achieve a clinically meaningful reduction in depression symptoms and were more likely to relapse sooner after the infusion series ended. The findings suggest that age is a key patient characteristic influencing the speed and durability of ketamine's antidepressant effects.